THE CENTRE FOR DRUG RESEARCH AND DEVELOPMENT and the Ontario Institute for Cancer Research announced a call for pre-proposals from Canadian academic investigators focused on early-stage technologies.
The two organizations are looking to collaborate on projects that will advance the preclinical development of targeted therapeutics or approaches including small molecules, biologics and cell-based therapies.
Unlike traditional grants, CDRD and OICR will work in partnership with academic investigators to develop collaborative project plans addressing the steps required to advance cancer therapies from the lab to the clinic. Projects will be milestone-driven with clear go/no-go decision points with budgets depending on the scope of the project.
More information on the program can be found on the CDRD website.
